11.04.2013
- A spike in U.S. demand for flu drug Tamiflu and strong sales of mainstay cancer medicines lifted first-quarter sales at Roche by a bigger-than-expected 5%. The healthy performance...
30.01.2013
- Swiss drugmaker Roche expects sales to hold up this year as strong sales of its top three cancer medicine and improvements in productivity pushed it to an 11 % rise in full-year...
